I now have comprehensive material from both Andrews' and Fitzpatrick's. Here is the full treatment guide:
Foot Lesion Treatment Guide
Pitted Keratolysis & Plantar Warts
How to Tell Them Apart First
Before treating, confirm which condition you are dealing with - they look similar but have very different causes and treatments.
| Feature | Pitted Keratolysis | Plantar Wart |
|---|
| Cause | Bacterial (Kytococcus sedentarius, Corynebacterium spp.) | HPV types 1, 2, 27, 57 |
| Appearance | Multiple tiny crater-like pits, may coalesce | Firm, raised papule with central pulpy core |
| Skin ridge lines | Intact - lines run through the lesion | Disrupted - lines go around the lesion |
| Black dots | Shallow dark pits (bacterial activity) | Thrombosed capillaries (bleed when pared) |
| Pain | Usually none; 1/3 have burning/irritation | Often painful with walking |
| Odor | Characteristic bad smell (~2/3 of cases) | None |
| Slimy feet | Yes - foot sticks to socks (~70% of cases) | No |
| Location | Heel, ball, toe pads (weight-bearing areas) | Ball of foot, midmetatarsal area; can be anywhere on sole |
| Wood's lamp | No fluorescence | No fluorescence |
PART 1: PITTED KERATOLYSIS
What Is It?
A superficial, non-inflammatory bacterial infection of the stratum corneum (outer skin layer) of the plantar foot. The bacteria produce serine proteases that digest keratin, creating crater-like pits. Sulfur compounds released in this process cause the characteristic malodor. - Fitzpatrick's Dermatology, Vol. 1-2
Most susceptible: Adult males with hyperhidrosis (~90% of cases, male:female ratio ~8:1). Hot, humid climates and occlusive footwear are key risk factors.
Step 1: Confirm the Diagnosis
- Diagnosis is clinical - the appearance alone is usually enough
- Gram stain of skin scrapings can detect the organisms
- Bacterial culture is not helpful (multiple species grow out)
- Biopsy is rarely needed; if done, Gram/PAS/methenamine silver stains show cocci and filamentous bacteria in pit walls
Step 2: Control Hyperhidrosis (Root Cause)
Keeping the feet dry is the most important step. Without this, the condition will recur even after antibiotic treatment.
| Agent | How to Use |
|---|
| Aluminum chloride 20% solution | Apply to dry skin at night; first-line antiperspirant for feet |
| Topical glycopyrrolate | Applied topically for localized hyperhidrosis |
| Botulinum toxin (Botox) | Injected into soles for severe/recalcitrant hyperhidrosis; highly effective but requires a specialist |
| Absorbent foot powder (inert antiseptic) | Daily use in socks and shoes to absorb moisture |
Step 3: Topical Antibiotics / Antimicrobials
These are curative in the majority of cases. Apply twice daily for 2-4 weeks.
| Agent | Type | Notes |
|---|
| Erythromycin 2% solution/gel | Topical antibiotic | Highly effective, first-line |
| Clindamycin 1% solution/lotion | Topical antibiotic | First-line alternative |
| Mupirocin 2% cream | Topical antibiotic | Effective; good for localized areas |
| 5% Benzoyl peroxide gel/cleanser | Antimicrobial | Effective; also helps with odor; apply as wash or leave-on |
| Fusidic acid cream | Topical antibiotic | Used as adjunctive agent |
| Miconazole or clotrimazole cream | Azole antifungal | Effective; useful if concurrent tinea pedis is suspected |
| Aluminum chloride 10-20% | Drying + antimicrobial | Can be used alongside antibiotics |
Tip: Combining a topical antibiotic with a keratolytic enhances drug penetration into the thickened stratum corneum.
Step 4: Keratolytics (for thickened/hyperkeratotic skin)
Add a keratolytic to soften the thick overlying stratum corneum and improve antibiotic penetration:
- Urea cream (10-40%) - softens and exfoliates thickened skin
- Salicylic acid 5-20% - peels away stratum corneum
- Lactic acid cream - gentle keratolytic, good for daily use
Step 5: Systemic Antibiotics (Severe/Recalcitrant Cases Only)
Reserve for widespread involvement or failure of topical treatment after 4-6 weeks:
- Clarithromycin - single dose (reported effective)
- Erythromycin oral - 2-week course
- Clindamycin oral - short course
Prevention & Hygiene Protocol
This is as important as treatment to prevent recurrence:
- Change socks daily - wash socks at 60°C (140°F) minimum to kill bacteria
- Change shoes regularly - allow shoes to fully dry between wearings; alternate pairs
- Avoid occlusive footwear (rubber-soled, non-breathable shoes) as much as possible
- Wear moisture-wicking socks (synthetic or wool, not cotton)
- Dry feet thoroughly after bathing, especially between toes
- Antibacterial soap for feet during bathing helps reduce recurrence
- Foot powder in shoes daily
Expected Timeline
- Symptoms improve within 1-2 weeks of topical treatment
- Full resolution: 3-4 weeks with consistent treatment
- Without hyperhidrosis control: high likelihood of recurrence
PART 2: PLANTAR WARTS (Verruca Plantaris)
What Is It?
A viral skin infection caused by Human Papillomavirus (HPV) types 1, 2, 27, and 57. The virus causes keratinocyte proliferation, forming a firm, hyperkeratotic papule on the sole. Plantar warts are notoriously more resistant to treatment than warts elsewhere. - Andrews' Diseases of the Skin, Clinical Dermatology
Key point: Many plantar warts, especially in children under 12, will resolve spontaneously without treatment. No treatment is a valid option to discuss.
Indications to treat: Pain, interference with walking, social embarrassment, or risk of spreading.
Therapeutic Options (Stepwise)
TIER 1 - Patient-Applied / Conservative (Start Here)
A. Salicylic Acid (10-26% OTC solutions, 40% prescription pads)
Best evidence for patient-applied therapy.
How to use:
- Soak affected area in warm water for 5-10 minutes
- Gently file dead skin with pumice stone, emery board, or table knife (clean between uses)
- Apply salicylic acid solution or gel; allow to dry
- Cover with a strip bandage or occlusive tape for 24 hours
- Repeat daily
- Continue for at least 3 months - do not stop too early
Efficacy: Some studies show parity with cryotherapy; others show it to be inferior. Results are better with consistent application and mechanical debridement.
B. Occlusive Tape (Duct Tape)
- Modest evidence; inferior to cryotherapy in adults
- Keep wart covered 6.5-7 days/week with a relatively impermeable tape
- Best reserved for: children under 12 (high spontaneous resolution rate) or patients refusing other treatments
- Adults: only ~20% resolve with 2 months of tape; 75% of "resolved" warts recur
TIER 2 - In-Office Procedures
A. Cryotherapy (Liquid Nitrogen) - First-line in-office treatment
- Cure rate: 20-50% with repeated applications
- Method: Sustained 10-second freeze with spray gun; freeze to produce 2-3 mm halo around wart
- A blister should form 1-2 days after treatment (this is the goal)
- Freeze-thaw cycle: a single cycle may be as effective as two
- Repeat every 2-3 weeks, just as the old blister peels off
- Liquid nitrogen (lower temperature) is preferred over other cryogens
- Side effects: Pain (can be significant for several days), hypopigmentation, scarring (rare), nerve damage if frozen too deeply at digit sides
- Contraindications/caution: Fanconi anemia, cryoglobulinemia, Raynaud phenomenon, poor peripheral circulation (severe blistering risk)
B. Cantharidin (0.7% cantharidin / "cantharone")
- Applied in office, covered with occlusive tape for 24 hours (or until burning)
- Blister forms in 24-72 hours (can be very painful)
- Repeat every 2-3 weeks
- Advantage: Painless to apply - good for children
- Disadvantage: Can produce "doughnut warts" (ring-shaped recurrence)
C. Intralesional Candida Antigen Injection
- Inject 0.1 mL into 1-3 lesions; repeat every 3-4 weeks
- Cure rate up to 80% with multiple treatments; highly effective
- Works by triggering local immune response that generates systemic HPV immunity
- Side effects: Fever, chills, flu-like symptoms 6-8 hours post-injection (cytokine-mediated); resolves within 24-48 hours. Advise patients in advance.
TIER 3 - Immunologic Therapy
A. Topical Sensitizers (DNCB, Squaric Acid Dibutyl Ester, Diphencyprone)
- Patients sensitized at distant site (inner upper arm) first, then applied to warts
- Two protocols: high-concentration in-office (2-5% every 2 weeks) vs. take-home lower concentration (0.2-0.5% up to daily)
- Keep covered 24 hours after application
- Wart resolution begins in 1-2 weeks but typically requires 2-3+ months
- Overall cure rates for all three sensitizers: 60-80%
- Side effects: Local itch, pain, mild eczema; usually no functional limitation
B. Oral Cimetidine (25-40 mg/kg/day)
- Anecdotally reported to help via immunomodulatory effects
- Single-agent efficacy is low (~30%, similar to placebo)
- May be useful as an adjunct to immunotherapy when response is sluggish
- Limited side effects
C. Imiquimod
- Evidence for common/plantar warts is weak - cure rates ~10%, comparable to placebo in controlled trials
- Not routinely recommended for plantar warts
TIER 4 - Surgical / Laser (Refractory Cases Only)
Use when multiple in-office treatments over 3+ months have failed.
A. Pulsed Dye Laser (PDL)
- High fluences (12.5-15 J/cm², mean 14 J/cm²) with 1.5 ms pulse duration, 7 mm spot
- Extends 2 mm beyond visible wart margin
- Local anesthesia required in most patients
- Skin turns gray-black immediately; eschar forms over 10-14 days
- Repeat every 2-4 weeks as eschar falls off
- Efficacy for refractory warts: 70-90% in immunocompetent patients
- Also works for periungual warts (penetrates nail plate)
B. CO2 Laser
- Requires local anesthesia; produces scarring and may cause nail dystrophy
- Efficacy: 56-81% for refractory warts
- Produces potentially infectious plume - appropriate precautions required
C. Surgical Ablation
- Last resort; even complete excision of wart + surrounding skin does not guarantee non-recurrence
- Reserve for warts refractory to all conservative approaches
D. Bleomycin Injection (1 U/mL)
- Injected into wart until blanching; or multipuncture technique (Shelley method)
- Reserved for recalcitrant common warts in adults
- High efficacy but significant local side effects
Special Considerations
Children under 12: Spontaneous resolution is common. Favor watchful waiting, duct tape, or salicylic acid first. Aggressive cryotherapy should be used cautiously.
Immunocompromised patients: Warts are more extensive, more resistant to treatment, and require more aggressive/longer management. Risk of HPV-induced malignancy is higher - monitor closely.
Mosaic warts (multiple confluent warts): More resistant to all treatments. Require combination approaches and longer treatment duration.
When to Refer
- No response after 3 months of consistent treatment
- Wart disrupting normal function or gait
- Immunocompromised patient with extensive warts
- Any lesion with atypical appearance (ulceration, marked bleeding, unusual growth) - biopsy to rule out malignancy, particularly epithelioid sarcoma
Sources: Andrews' Diseases of the Skin: Clinical Dermatology | Fitzpatrick's Dermatology, Vol. 1-2 | Dermatology 2-Volume Set 5e (Elsevier)